Industry News

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Food and Beverages
Healthcare- Biotechnology
Healthcare- Medical Devices

Using nanoparticles to address immune tolerance

Selecta Bioscience’s ImmTOR platform could improve gene therapies and prevent some drug side effects.

Draft Text of Proposed New Section 101 Reflects Patent Owner Input

The Supreme Court should never have created its own exceptions to U.S. patent laws. It has taken far too long for Congress to finally correct these errors, but this draft bill would finally strengthen our patent system.

Construction of synthetic genome of Escherichia coli with fewer codons

The biggest synthetic genome so far has been made, with a smaller set of amino-acid-encoding codons than usual — raising the prospect of encoding proteins that contain unnatural amino-acid residues.

Three Firms Combine to Create New Decommissioning Company in Aberdeen

AF Gruppen’s subsidiary AF Offshore Decom is joining forces with offshore decommissioning players Heerema Marine Contractors and Decom Energy to launch a new company: Fairfield Decom.

AZ confirms cardiovascular safety with roxadustat results

AstraZeneca has announced top-line results from the pooled cardiovascular (CV) safety analyses of its global Phase III roxadustat programme.

Prostate tumours are invaded by nerve cells from the brain

Prostate cancer contains nerve cells that are linked to disease progression, but their source was unknown. A mouse study reveals that cells from the brain invade prostate tumours and give rise to this nerve-cell population.

Saudi Pipeline Shut Down After Sophisticated Drone Attack

A MAJOR OIL PIPELINE IN Saudi Arabia was struck by armed drones and temporarily shut down, the kingdom’s energy minister said Tuesday, calling the move an “act of terrorism and sabotage” that marks the second attack on the Saudi oil infrastructure in as many days.

FDA approval for Bavencio combo in advanced RCC

The US Food and Drug Administration (FDA) has approved Merck’s Bavencio (avelumab) plus Inlyta (axitinib) combination for patients with advanced renal cell carcinoma.

Novartis to acquire Xiidra®, expanding front-of-eye portfolio and strengthening leadership in eye care

Novartis has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with Xiidra® (lifitegrast ophthalmic solution) 5% worldwide.


Electric vans, utes and eventually cars will be assembled in Adelaide from next year, with start-up company ACE EV to sign an agreement with an Adelaide-based business today.

Subscribe to Newsletter

IEBS Insights

Case Studies